SMOX and diabetic retinopathy: Recent studies from our lab investigated the impact of SMOX inhibition via MDL 72527 treatment in the models of retinal excitotoxicity [37,39] and diabetic retinopathy (DR) [36,38], and indicated that SMOX inhibition is capable of suppressing retinal inflammation and reducing neuronal damage.